Pulse lineResearch With Heart Logo

ARIC Publications

Filters: First Letter Of Last Name is A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Chen H, Mosley TH, Alonso A, Huang X. "Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study." Am J Epidemiol. 2009;169(9):1064-9.
Berger D, Folsom AR, Schreiner PJ, et al. "Plasma total testosterone and risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study." Maturitas. 2019;125:5-10.
Li D, Misialek JR, Boerwinkle E, et al. "Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS)." Alzheimers Dement (Amst). 2016;3:73-82.
Li D, Misialek JR, Jing M, et al. "Plasma phospholipid very-long-chain SFAs in midlife and 20-year cognitive change in the Atherosclerosis Risk in Communities (ARIC): a cohort study." Am J Clin Nutr. 2020;111(6):1252-1258.
Li D, Misialek JR, Jack CR, et al. "Plasma Metabolites Associated with Brain MRI Measures of Neurodegeneration in Older Adults in the Atherosclerosis Risk in Communities⁻Neurocognitive Study (ARIC-NCS)." Int J Mol Sci. 2019;20(7).
Shahar E, Chambless LE, Rosamond WD, et al. "Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2003;34(3):623-31.
Voight BF, Peloso GM, Orho-Melander M, et al. "Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study." Lancet. 2012;380(9841):572-80.
Voight BF, Peloso GM, Orho-Melander M, et al. "Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study." Lancet. 2012;380(9841):572-80.
Voight BF, Peloso GM, Orho-Melander M, et al. "Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study." Lancet. 2012;380(9841):572-80.
Voight BF, Peloso GM, Orho-Melander M, et al. "Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study." Lancet. 2012;380(9841):572-80.
Rebholz CM, Selvin E, Liang M, et al. "Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease." Kidney Int. 2018;93(1):252-259.
Oyenuga A, Folsom AR, Fashanu O, Aguilar D. "Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study." Angiology. 2019;70(1):47-55.
Yamagishi K, Folsom AR. "Plasma fatty acid composition and incident ischemic stroke in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Cerebrovasc Dis. 2013;36(1):38-46.
Yamagishi K, Nettleton JA, Folsom AR. "Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Am Heart J. 2008;156(5):965-74.
Wang L, Folsom AR, Zheng Z-jie, Pankow JS, Eckfeldt JH. "Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Clin Nutr. 2003;78(1):91-8.
Zheng ZJ, Folsom AR, Ma J, Arnett DK, McGovern PG, Eckfeldt JH. "Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Epidemiol. 1999;150(5):492-500.
Folsom AR, Gottesman RF, Appiah D, Shahar E. "Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study." Stroke. 2016;47(1):18-23.
Prizment AE, Folsom AR, Dreyfus J, et al. "Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study." Cancer Causes Control. 2013;24(12):2077-87.
Damotte V, van der Lee SJ, Chouraki V, et al. "Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants." Alzheimers Dement. 2021.
Damotte V, van der Lee SJ, Chouraki V, et al. "Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants." Alzheimers Dement. 2021.
Damotte V, van der Lee SJ, Chouraki V, et al. "Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants." Alzheimers Dement. 2021.
Damotte V, van der Lee SJ, Chouraki V, et al. "Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants." Alzheimers Dement. 2021.
Huxley RR, Misialek JR, Agarwal SK, Loehr LR, Soliman EZ, Chen LYee. "Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study." Circ Arrhythm Electrophysiol. 2014;7(4):620-5.
Huxley RR, Misialek JR, Agarwal SK, Loehr LR, Soliman EZ, Chen LYee. "Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study." Circ Arrhythm Electrophysiol. 2014;7(4):620-5.
Pereira MA, Folsom AR, McGovern PG, et al. "Physical activity and incident hypertension in black and white adults: the Atherosclerosis Risk in Communities Study." Prev Med. 1999;28(3):304-12.
Folsom AR, Arnett DK, Hutchinson RG, Liao F, Clegg LX, Cooper LS. "Physical activity and incidence of coronary heart disease in middle-aged women and men." Med Sci Sports Exerc. 1997;29(7):901-9.
Pendergrass SA, Buyske S, Jeff JM, et al. "A phenome-wide association study (PheWAS) in the Population Architecture using Genomics and Epidemiology (PAGE) study reveals potential pleiotropy in African Americans." PLoS One. 2019;14(12):e0226771.
Pendergrass SA, Buyske S, Jeff JM, et al. "A phenome-wide association study (PheWAS) in the Population Architecture using Genomics and Epidemiology (PAGE) study reveals potential pleiotropy in African Americans." PLoS One. 2019;14(12):e0226771.
Pendergrass SA, Brown-Gentry K, Dudek S, et al. "Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) Network." PLoS Genet. 2013;9(1):e1003087.
Pendergrass SA, Brown-Gentry K, Dudek S, et al. "Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) Network." PLoS Genet. 2013;9(1):e1003087.
Seyerle AA, Sitlani CM, Noordam R, et al. "Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology." Pharmacogenomics J. 2018;18(2):215-226.
Floyd JS, Bloch KM, Brody JA, et al. "Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing." PLoS One. 2019;14(6):e0218115.
Floyd JS, Bloch KM, Brody JA, et al. "Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing." PLoS One. 2019;14(6):e0218115.
Postmus I, Trompet S, Deshmukh HA, et al. "Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins." Nat Commun. 2014;5:5068.
Postmus I, Trompet S, Deshmukh HA, et al. "Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins." Nat Commun. 2014;5:5068.
Postmus I, Trompet S, Deshmukh HA, et al. "Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins." Nat Commun. 2014;5:5068.
Postmus I, Trompet S, Deshmukh HA, et al. "Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins." Nat Commun. 2014;5:5068.
Zhang S, Philips KH, Moss K, et al. "Periodontitis and Risk of Diabetes in the Atherosclerosis Risk In Communities (ARIC) Study: A BMI-modified Association." J Clin Endocrinol Metab. 2021.
Sen S, Redd K, Trivedi T, et al. "Periodontal Disease, Atrial Fibrillation and Stroke." Am Heart J. 2021;235:36-43.
Pandey A, Mehta A, Paluch A, et al. "Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels." JAMA Cardiol. 2021;6(6):690-696.
Tabor HK, Auer PL, Jamal SM, et al. "Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results." Am J Hum Genet. 2014;95(2):183-93.
Dixit S, Alonso A, Vittinghoff E, Soliman EZ, Chen LYee. "Past alcohol consumption and incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study." PLoS One. 2017;12(10):e0185228.
Nicholson WK, Asao K, Brancati F, Coresh J, Pankow JS, Powe NR. "Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study." Diabetes Care. 2006;29(11):2349-54.
Perry JRb, Day F, Elks CE, et al. "Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche." Nature. 2014;514(7520):92-97.
Perry JRb, Day F, Elks CE, et al. "Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche." Nature. 2014;514(7520):92-97.
Perry JRb, Day F, Elks CE, et al. "Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche." Nature. 2014;514(7520):92-97.
Perry JRb, Day F, Elks CE, et al. "Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche." Nature. 2014;514(7520):92-97.
Perry JRb, Day F, Elks CE, et al. "Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche." Nature. 2014;514(7520):92-97.
Perry JRb, Day F, Elks CE, et al. "Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche." Nature. 2014;514(7520):92-97.
Perry JRb, Day F, Elks CE, et al. "Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche." Nature. 2014;514(7520):92-97.
Perry JRb, Day F, Elks CE, et al. "Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche." Nature. 2014;514(7520):92-97.
Folsom AR, Alonso A, Misialek JR, et al. "Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2014;168(3):296-302.
Yao L, Folsom AR, Pankow JS, et al. "Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study." J Hypertens. 2016;34(2):196-203.
Korada SKrishna C, Zhao D, Gottesman RF, et al. "Parathyroid Hormone and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study." J Stroke Cerebrovasc Dis. 2016;25(4):883-93.
Magnani JW, Lopez FL, Soliman EZ, Maclehose RF, Crow RS, Alonso A. "P wave indices, obesity, and the metabolic syndrome: the atherosclerosis risk in communities study." Obesity (Silver Spring). 2012;20(3):666-72.
O
Olden M, Teumer A, Bochud M, et al. "Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium." Am J Kidney Dis. 2013;61(6):889-98.
Caughey MC, Avery CL, Ni H, et al. "Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance)." Am J Cardiol. 2014;114(12):1850-4.
Arora S, Cavender MA, Chang PP, et al. "Outcomes of decreasing versus increasing cardiac troponin in patients admitted with non-ST-segment elevation myocardial infarction: the Atherosclerosis Risk in Communities Surveillance Study." Eur Heart J Acute Cardiovasc Care. 2019:2048872619842983.
Juraschek SP, Daya N, Appel LJ, et al. "Orthostatic Hypotension in Middle-Age and Risk of Falls." Am J Hypertens. 2017;30(2):188-195.
Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. "Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996." Stroke. 2000;31(10):2307-13.
Rose KM, Tyroler HA, Nardo CJ, et al. "Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study." Am J Hypertens. 2000;13(6 Pt 1):571-8.
Bell EJ, Agarwal SK, Cushman M, Heckbert SR, Lutsey PL. "Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies." Am J Hypertens. 2016;29(5):634-40.
Juraschek SP, Daya N, Appel LJ, et al. "Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle-Aged Adults." J Am Heart Assoc. 2018;7(10).
Fedorowski A, Franceschini N, Brody J, et al. "Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium." Eur Heart J. 2012;33(18):2331-41.
Franceschini N, Rose KM, Astor BC, Couper D, Vupputuri S. "Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study." Hypertension. 2010;56(6):1054-9.
Agarwal SK, Alonso A, Whelton SP, et al. "Orthostatic change in blood pressure and incidence of atrial fibrillation: results from a bi-ethnic population based study." PLoS One. 2013;8(11):e79030.
Agarwal SK, Alonso A, Whelton SP, et al. "Orthostatic change in blood pressure and incidence of atrial fibrillation: results from a bi-ethnic population based study." PLoS One. 2013;8(11):e79030.
Nunez E, Arnett DK, Benjamin EJ, et al. "Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study." Hypertension. 2005;45(1):58-63.
Nunez E, Arnett DK, Benjamin EJ, et al. "Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study." Hypertension. 2005;45(1):58-63.
Evenson KR, Rosamond WD, Cai J, Pereira MA, Ainsworth BE. "Occupational physical activity in the atherosclerosis risk in communities study." Ann Epidemiol. 2003;13(5):351-7.
Lutsey PL, Bengtson LGS, Punjabi NM, et al. "Obstructive Sleep Apnea and 15-Year Cognitive Decline: The Atherosclerosis Risk in Communities (ARIC) Study." Sleep. 2016;39(2):309-16.
Adabag S, Huxley RR, Norby FL, et al. "Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study." Heart. 2015;101(3):215-21.
Adabag S, Huxley RR, Norby FL, et al. "Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study." Heart. 2015;101(3):215-21.
Dearborn JL, Schneider ALC, Sharrett ARichey, et al. "Obesity, Insulin Resistance, and Incident Small Vessel Disease on Magnetic Resonance Imaging: Atherosclerosis Risk in Communities Study." Stroke. 2015;46(11):3131-6.
Wofford MR, Andrew ME, Brown A, et al. "Obesity Hypertension in the Atherosclerosis Risk in Communities Cohort: Implications of Obesity Guidelines." J Clin Hypertens (Greenwich). 1999;1(1):27-32.
N
Ndumele CE, Matsushita K, Sang Y, et al. "N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 2016;133(7):631-8.
Whitman IR, Vittinghoff E, Defilippi CR, et al. "NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure." J Am Heart Assoc. 2019;8(7):e010868.
Whitman IR, Vittinghoff E, Defilippi CR, et al. "NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure." J Am Heart Assoc. 2019;8(7):e010868.
Heard-Costa NL, Zillikens CM, Monda KL, et al. "NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium." PLoS Genet. 2009;5(6):e1000539.
Heard-Costa NL, Zillikens CM, Monda KL, et al. "NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium." PLoS Genet. 2009;5(6):e1000539.

Pages